AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 616788562 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (8 weeks, 3 sessions per week, each session 65 minutes)
Number of subjects: 16
Study 616788562 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 16
Study 33519166 — intervention group
Group type: EXPERIMENTAL
Intervention: Food insecure group
Number of subjects: 102
Study 35817131 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm Nut (hazelnut cocoa palm oil-rich spread)
Number of subjects: 30
Study 35817131 — intervention group
Group type: EXPERIMENTAL
Intervention: Butter
Number of subjects: 30
Study 35817131 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 30
Study 32889876 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic Distal Gastrectomy (RDG)
Number of subjects: 300
Study 32889876 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Distal Gastrectomy (LDG)
Number of subjects: 300
Study 33278521 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 3004
Study 33278521 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal Intubation (ETI)
Number of subjects: 3004
Study 33278521 — intervention group
Group type: COMPARATOR
Intervention: Control (Bag-valve-mask ventilation only)
Number of subjects: 3004
Study 33278521 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (LT and ETI)
Number of subjects: 3004
Study 32908914 — intervention group
Group type: EXPERIMENTAL
Intervention: Wooden skull models
Number of subjects: 120
Study 32908914 — intervention group
Group type: COMPARATOR
Intervention: Natural skull models (Control)
Number of subjects: 120
Study 36451109 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics signature (radscore)
Number of subjects: 152
Study 36451109 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 152
Study 36451109 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics models (both signature and nomogram)
Number of subjects: 152
Study 34916636 — intervention group
Group type: EXPERIMENTAL
Intervention: Saltwater mouth rinse
Number of subjects: 37
Study 34916636 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine mouth rinse
Number of subjects: 37
Study 34293018 — intervention group
Group type: EXPERIMENTAL
Intervention: High-compliance matting
Number of subjects: 27
Study 34293018 — intervention group
Group type: COMPARATOR
Intervention: Low-compliance matting
Number of subjects: 27
Study 34293018 — intervention group
Group type: COMPARATOR
Intervention: Low-compliance matting with a backboard
Number of subjects: 27
Study 32507132 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) treatment, 12 min/session, three sessions/week for four weeks.
Number of subjects: 20
Study 32507132 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (control group), blinded to participants, for two weeks.
Number of subjects: 20
Study 35484279 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention group (MIG)
Number of subjects: 72
Study 35484279 — intervention group
Group type: COMPARATOR
Intervention: Control group (CTRL)
Number of subjects: 72
Study 34444974 — intervention group
Group type: EXPERIMENTAL
Intervention: BB-12 yogurt
Number of subjects: 62
Study 34444974 — intervention group
Group type: COMPARATOR
Intervention: Control yogurt
Number of subjects: 62
Study 32331031 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback and analgesics
Number of subjects: 50
Study 32331031 — intervention group
Group type: COMPARATOR
Intervention: Analgesics alone
Number of subjects: 50
Study 35136116 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet perlite
Number of subjects: 13
Study 35136116 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry perlite
Number of subjects: 13
Study 35136116 — intervention group
Group type: COMPARATOR
Intervention: High density snow
Number of subjects: 13
Study 33864139 — intervention group
Group type: EXPERIMENTAL
Intervention: MF-based radiomic signature
Number of subjects: 217
Study 33864139 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomic-clinical nomogram
Number of subjects: 217
Study 33864139 — intervention group
Group type: COMPARATOR
Intervention: MV-based radiomic signature
Number of subjects: 217
Study 33864139 — intervention group
Group type: COMPARATOR
Intervention: Clinico-radiological signature
Number of subjects: 217
Study 32355569 — intervention group
Group type: COMPARATOR
Intervention: ES+HIV
Number of subjects: 1773
Study 32355569 — intervention group
Group type: COMPARATOR
Intervention: ES-only
Number of subjects: 1773
Study 32355569 — intervention group
Group type: COMPARATOR
Intervention: HIV-only
Number of subjects: 1773
Study 32355569 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1773
Study 35260450 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors and angiotensin receptor blockers
Number of subjects: 0
Study 36435541 — intervention group
Group type: EXPERIMENTAL
Intervention: Building Closer Friendships (BCF)
Number of subjects: 55
Study 36435541 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 55
Study 32556113 — intervention group
Group type: EXPERIMENTAL
Intervention: TwinrabTM (docaravimab and miromavimab)
Number of subjects: 308
Study 32556113 — intervention group
Group type: COMPARATOR
Intervention: HRIG (Imogam® Rabies‐HT)
Number of subjects: 308
Study 32130125 — intervention group
Group type: EXPERIMENTAL
Intervention: Community antistigma campaign with training of lay village health workers and primary care doctors; use of electronic clinical decision support system.
Number of subjects: 900
Study 35993376 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement with IT posts
Number of subjects: 869
Study 35993376 — intervention group
Group type: COMPARATOR
Intervention: Control (prescription drug misuse posts)
Number of subjects: 869
Study 34735908 — intervention group
Group type: EXPERIMENTAL
Intervention: RPGE (375 mg, 2 tablets, 2 times/day)
Number of subjects: 100
Study 34735908 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32847622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health First Aid (MHFA) training package (2-day standard course)
Number of subjects: 25
Study 32847622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health First Aid (MHFA) training package (1-day course)
Number of subjects: 25
Study 32847622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health awareness-raising session
Number of subjects: 25
Study 32847622 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support service
Number of subjects: 25
Study 32847622 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support service re-advertisement
Number of subjects: 25
Study 32847622 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidelity of MHFA training delivery
Number of subjects: 25
Study 32847622 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to operational guidelines for peer support service
Number of subjects: 25
Study 35149326 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (50 mg/day)
Number of subjects: 51
Study 35149326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 34503629 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone ester (KE) drink
Number of subjects: 11
Study 34503629 — intervention group
Group type: COMPARATOR
Intervention: Placebo control drink
Number of subjects: 11
Study 32371670 — intervention group
Group type: EXPERIMENTAL
Intervention: Lu-DOTATATE + capecitabine
Number of subjects: 8
Study 34396784 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted state (high NEFA levels)
Number of subjects: 9
Study 34396784 — intervention group
Group type: COMPARATOR
Intervention: Glucose-fed state (low NEFA levels)
Number of subjects: 9
Study 36168956 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic temperature control (32-34°C for 24 hours)
Number of subjects: 249
Study 36168956 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (controlled at 37.0°±0.9°C for 48 hours)
Number of subjects: 249
Study 33908297 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal superficial femoral vein (DSFV)
Number of subjects: 60
Study 33908297 — intervention group
Group type: COMPARATOR
Intervention: Axillary vein (AV)
Number of subjects: 60
Study 32682074 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI (160/7.2/4.8 μg per actuation) with a 10-second breath-hold
Number of subjects: 10
Study 32682074 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI (160/7.2/4.8 μg per actuation) with a 3-second breath-hold
Number of subjects: 10
Study 32682074 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI (160/7.2/4.8 μg per actuation)
Number of subjects: 10
Study 35689881 — intervention group
Group type: EXPERIMENTAL
Intervention: uPA positive tumors
Number of subjects: 303
Study 35689881 — intervention group
Group type: COMPARATOR
Intervention: PAI-1 expression
Number of subjects: 303
Study 35689881 — intervention group
Group type: COMPARATOR
Intervention: uPA/PAI-1 ratio
Number of subjects: 303
Study 34497027 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (stimulated on bilateral Zusanli, Shangjuxu, and Sanyinjiao acupoints in lower limbs for 30 minutes each time, total 4 times)
Number of subjects: 610
Study 34497027 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (without currents delivered)
Number of subjects: 610
Study 34497027 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation
Number of subjects: 610
Study 34312156 — intervention group
Group type: EXPERIMENTAL
Intervention: Kilkari mobile health messaging program
Number of subjects: 54
Study 34999268 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic and resistance exercise (EX)
Number of subjects: 135
Study 34999268 — intervention group
Group type: COMPARATOR
Intervention: Health education control (HE)
Number of subjects: 135
Study 34999268 — intervention group
Group type: EXPERIMENTAL
Intervention: Craving during treatment
Number of subjects: 135
Study 33947608 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib monotherapy
Number of subjects: 1955
Study 33947608 — intervention group
Group type: COMPARATOR
Intervention: Axitinib + IO
Number of subjects: 1955
Study 33947608 — intervention group
Group type: COMPARATOR
Intervention: Other TKI
Number of subjects: 1955
Study 32109422 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 53
Study 32109422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 34610482 — intervention group
Group type: EXPERIMENTAL
Intervention: solriamfetol
Number of subjects: 64
Study 34610482 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 64
Study 35473742 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health intervention (informational and testimonial video about opioid tapering + two text messages per day for 28 days)
Number of subjects: 40
Study 35473742 — intervention group
Group type: COMPARATOR
Intervention: Usual care (multidisciplinary pain management)
Number of subjects: 40
Study 34953185 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen lysine salt solution
Number of subjects: 100
Study 34953185 — intervention group
Group type: COMPARATOR
Intervention: Native vitamin D prescriptions
Number of subjects: 100
Study 33878069 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibular nail
Number of subjects: 125
Study 33878069 — intervention group
Group type: COMPARATOR
Intervention: Plate fixation
Number of subjects: 125
Study 33177243 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing years of schooling
Number of subjects: 0
Study 33177243 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically elevated HDL cholesterol
Number of subjects: 0
Study 33177243 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted total cholesterol
Number of subjects: 0
Study 33177243 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted LDL cholesterol
Number of subjects: 0
Study 33177243 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted FG
Number of subjects: 0
Study 33177243 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-BMA analysis
Number of subjects: 0
Study 35639365 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee (2 cups per day, total amount 160 mg caffeine)
Number of subjects: 48
Study 35639365 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Tea (3 cups per day, total amount 252 mg catechin and 96 mg caffeine)
Number of subjects: 48
Study 35639365 — intervention group
Group type: COMPARATOR
Intervention: Herbal Tea (placebo, 3 cups per day)
Number of subjects: 48
Study 33596746 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose 15 mL once daily
Number of subjects: 100
Study 33596746 — intervention group
Group type: COMPARATOR
Intervention: Sennosides two tablets daily
Number of subjects: 100
Study 32600454 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment (Nebido®)
Number of subjects: 40
Study 32600454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 36266481 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-ml 0.5% bupivacaine without epinephrine
Number of subjects: 70
Study 36266481 — intervention group
Group type: COMPARATOR
Intervention: 10 ml of 0.9% saline (control)
Number of subjects: 70
Study 33797983 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH)
Number of subjects: 108
Study 33797983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 35960116 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 42
Study 35960116 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 42
Study 34425346 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-MRI fusion combined with contrast-enhanced ultrasound (Observation group)
Number of subjects: 39
Study 34425346 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 39
Study 32723753 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual antipsychotic reduction and discontinuation
Number of subjects: 0
Study 32723753 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 0
Study 35868433 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg NVCM intravenously every 12 h and 16 mg NVCM intrathecal administration every 24 h
Number of subjects: 29
Study 35868433 — intervention group
Group type: COMPARATOR
Intervention: 800 mg NVCM intravenously every 12 h (Control)
Number of subjects: 29
Study 33649919 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial use of oral sodium alginate (arm A)
Number of subjects: 94
Study 33649919 — intervention group
Group type: EXPERIMENTAL
Intervention: Late use of oral sodium alginate (arm B)
Number of subjects: 94
Study 33649919 — intervention group
Group type: COMPARATOR
Intervention: Water as control (arm C)
Number of subjects: 94
Study 32723991 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-weekly docetaxel for 8 cycles
Number of subjects: 10
Study 35411939 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC + AAP (Abiraterone acetate 1000 mg + Prednisolone 5 mg)
Number of subjects: 1003
Study 35411939 — intervention group
Group type: COMPARATOR
Intervention: SOC-alone (Standard-of-care androgen deprivation therapy)
Number of subjects: 1003
Study 36224521 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive GDM status
Number of subjects: 858
Study 36224521 — intervention group
Group type: EXPERIMENTAL
Intervention: One unit (kg) increase in birth weight
Number of subjects: 858
Study 36224521 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive GDM status (multivariate model)
Number of subjects: 858
Study 36224521 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrosomia status (multivariate model)
Number of subjects: 858
Study 32639561 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Therapy (BT)
Number of subjects: 211
Study 32639561 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 211
Study 32639561 — intervention group
Group type: EXPERIMENTAL
Intervention: BT to Zolpidem (second-stage therapy)
Number of subjects: 211
Study 32639561 — intervention group
Group type: EXPERIMENTAL
Intervention: BT to Cognitive Therapy (CT) (second-stage therapy)
Number of subjects: 211
Study 32639561 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem to Trazodone (second-stage therapy)
Number of subjects: 211
Study 33161159 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy
Number of subjects: 7750
Study 33161159 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly-prescribed medical therapy
Number of subjects: 7750
Study 33685044 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-lumen endotracheal intubation (group D)
Number of subjects: 180
Study 33685044 — intervention group
Group type: COMPARATOR
Intervention: Double-lumen endotracheal intubation (group S)
Number of subjects: 180
Study 33685044 — intervention group
Group type: COMPARATOR
Intervention: Coopdech occlusion of bronchial catheter combined with single-lumen endotracheal intubation (group C)
Number of subjects: 180
Study 33321778 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-induction technique (4% sevoflurane followed by 0.75 mg/kg propofol)
Number of subjects: 105
Study 33321778 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (8% with 100% oxygen at 8 L/min)
Number of subjects: 105
Study 33321778 — intervention group
Group type: COMPARATOR
Intervention: Propofol (1.5 mg/kg)
Number of subjects: 105
Study 33167849 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0
Study 33115480 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% or 80% assistance for foot clearance (FC)
Number of subjects: 9
Study 33115480 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% or 80% assistance for stability during stance (SS)
Number of subjects: 9
Study 33115480 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% or 80% assistance for weight shift (WS)
Number of subjects: 9
Study 33115480 — intervention group
Group type: COMPARATOR
Intervention: Baseline trial (no assistance)
Number of subjects: 9
Study 33115480 — intervention group
Group type: EXPERIMENTAL
Intervention: Assistance for leading limb angle subtask (via FC assistance)
Number of subjects: 9
Study 35609929 — intervention group
Group type: EXPERIMENTAL
Intervention: Exome sequencing
Number of subjects: 0
Study 35609929 — intervention group
Group type: EXPERIMENTAL
Intervention: Genome sequencing
Number of subjects: 0
Study 34324100 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone intravenously (IV) preoperatively
Number of subjects: 105
Study 34324100 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone from a nebulizer mask preoperatively
Number of subjects: 105
Study 34324100 — intervention group
Group type: COMPARATOR
Intervention: Nebulised normal saline
Number of subjects: 105
Study 34143199 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic activation of desensitizing agent (DA) containing 5% potassium nitrate and 2% sodium fluoride, activated for 30 seconds per tooth.
Number of subjects: 34
Study 34143199 — intervention group
Group type: COMPARATOR
Intervention: Desensitizing agent (DA) without sonic activation, applied for 10 minutes.
Number of subjects: 34
Study 34143199 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (SA and noSA)
Number of subjects: 34
Study 32772509 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based educational support intervention (eHES)
Number of subjects: 438
Study 32772509 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 438
Study 36445624 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided (GG) escalation of P2Y12 inhibitor therapy post PCI
Number of subjects: 539
Study 36445624 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-GG strategy)
Number of subjects: 539
Study 34510193 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic Acid (FA) supplementation (5 mg/d for 12 weeks)
Number of subjects: 177
Study 34510193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 36364727 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ)
Number of subjects: 16
Study 36364727 — intervention group
Group type: COMPARATOR
Intervention: Control beverage (prune juice: CON)
Number of subjects: 16
Study 35841243 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine Triphosphate (ATP) infusion
Number of subjects: 20
Study 35841243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 33631132 — intervention group
Group type: EXPERIMENTAL
Intervention: Irie Classroom Toolbox intervention
Number of subjects: 865
Study 33631132 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 865
Study 36327309 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal progesterone suppository
Number of subjects: 0
Study 36327309 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36231251 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT with BFR during interval (I)
Number of subjects: 72
Study 36231251 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT with BFR during exercise (E)
Number of subjects: 72
Study 36231251 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (H)
Number of subjects: 72
Study 36231251 — intervention group
Group type: COMPARATOR
Intervention: No-training control (C)
Number of subjects: 72
Study 34693504 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab plus best supportive care (BSC)
Number of subjects: 0
Study 34693504 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab plus BSC
Number of subjects: 0
Study 34693504 — intervention group
Group type: COMPARATOR
Intervention: PD-L1-guided strategy
Number of subjects: 0
Study 34693504 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab strategy
Number of subjects: 0
Study 33339976 — intervention group
Group type: COMPARATOR
Intervention: Conventional impression (Polyether)
Number of subjects: 10
Study 33339976 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerec digital scan
Number of subjects: 10
Study 33339976 — intervention group
Group type: EXPERIMENTAL
Intervention: iTero digital scan
Number of subjects: 10
Study 33339976 — intervention group
Group type: EXPERIMENTAL
Intervention: Lava digital scan
Number of subjects: 10